Concentrix (NASDAQ:CNXC) Trading Up 7% – What’s Next?

Concentrix Corporation (NASDAQ:CNXC)’s share price was up 7% during mid-day trading on Thursday . The company traded as high as $27.18 and last traded at $26.3950. Approximately 278,523 shares traded hands during mid-day trading, a decline of 81% from the average daily volume of 1,469,269 shares. The stock had previously closed at $24.67.

Key Concentrix News

Here are the key news stories impacting Concentrix this week:

• Positive Sentiment: Quarterly dividend announced (0.36/share; ~5.8% yield) gives income-oriented investors a concrete cash return and support under the share price.
• Positive Sentiment: Several firms maintained buy/outperform views despite trimming targets, keeping upside narratives alive (Barrington, Canaccord, Robert W. Baird). This analyst support likely helped stabilize buying interest. Analyst Coverage Summary
• Positive Sentiment: Management highlighted strong AI adoption and growth in banking verticals on the Q1 call, supporting a longer-term revenue/strategy thesis if margins recover. Q1 2026 Earnings Call Highlights
• Neutral Sentiment: Market mention coverage (e.g., Bloomberg “Stock Movers”) increased visibility but is informational rather than directional. Bloomberg Stock Movers
• Neutral Sentiment: Reports on short interest are inconsistent/erroneous in public filings for March (zero/NaN values), so short-squeeze dynamics appear unclear and shouldn’t be over-interpreted at this point.
• Negative Sentiment: Investors reacted to a margin squeeze and cautious 2026 guidance, which were flagged as the primary reasons for an earlier sharp drop in the stock; this guidance uncertainty is a near-term headwind. Why Concentrix Is Down 14%
• Negative Sentiment: Q1 showed an EPS miss (small) and margin pressure; coverage notes the stock hit a one-year low after the earnings surprise, highlighting execution and profitability risks. Sets New 1-Year Low After Earnings Miss
• Negative Sentiment: Critical analyst pieces and downgrades emphasize high leverage, negative Q1 free cash flow and execution risk during a costly AI transition — reasons some investors remain reluctant to buy despite low valuation. Seeking Alpha Downgrade Why I’m Not Buying

Analyst Upgrades and Downgrades

Several equities analysts have recently weighed in on CNXC shares. Wall Street Zen upgraded shares of Concentrix from a “hold” rating to a “buy” rating in a research note on Saturday, February 14th. Barrington Research cut their price objective on shares of Concentrix from $62.00 to $38.00 and set an “outperform” rating for the company in a report on Wednesday. Robert W. Baird reduced their price objective on shares of Concentrix from $52.00 to $40.00 and set an “outperform” rating for the company in a research note on Wednesday. Canaccord Genuity Group lowered their target price on shares of Concentrix from $80.00 to $55.00 and set a “buy” rating on the stock in a report on Wednesday. Finally, Weiss Ratings downgraded Concentrix from a “hold (c-)” rating to a “sell (d)” rating in a research report on Thursday, January 29th. Three analysts have rated the stock with a Buy rating, one has given a Hold rating and one has given a Sell rating to the stock. Based on data from MarketBeat.com, Concentrix currently has a consensus rating of “Hold” and a consensus target price of $48.50.

Concentrix Stock Up 10.4%

The stock has a fifty day simple moving average of $35.01 and a two-hundred day simple moving average of $40.22. The firm has a market cap of $1.67 billion, a PE ratio of -1.26, a price-to-earnings-growth ratio of 0.28 and a beta of 0.50. The company has a current ratio of 1.18, a quick ratio of 1.40 and a debt-to-equity ratio of 1.43.

Concentrix (NASDAQ:CNXC) last announced its quarterly earnings results on Tuesday, March 24th. The company reported $2.61 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $2.65 by ($0.04). The firm had revenue of $2.50 billion during the quarter, compared to analysts’ expectations of $2.49 billion. Concentrix had a positive return on equity of 17.80% and a negative net margin of 13.35%.The company’s quarterly revenue was up 5.4% compared to the same quarter last year. During the same period in the previous year, the company posted $2.79 earnings per share. As a group, sell-side analysts expect that Concentrix Corporation will post 10.11 EPS for the current fiscal year.

Concentrix Announces Dividend

The company also recently declared a quarterly dividend, which will be paid on Tuesday, May 5th. Shareholders of record on Friday, April 24th will be issued a $0.36 dividend. This represents a $1.44 annualized dividend and a yield of 5.3%. The ex-dividend date of this dividend is Friday, April 24th. Concentrix’s dividend payout ratio (DPR) is presently -6.91%.

Insider Activity at Concentrix

In other news, CEO Christopher A. Caldwell purchased 1,000 shares of the firm’s stock in a transaction dated Thursday, January 29th. The shares were purchased at an average price of $37.07 per share, with a total value of $37,070.00. Following the completion of the acquisition, the chief executive officer owned 362,075 shares in the company, valued at $13,422,120.25. This trade represents a 0.28% increase in their position. The acquisition was disclosed in a filing with the SEC, which is available through this hyperlink. 0.90% of the stock is owned by company insiders.

Hedge Funds Weigh In On Concentrix

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. AQR Capital Management LLC increased its stake in Concentrix by 1.8% in the 3rd quarter. AQR Capital Management LLC now owns 4,380,821 shares of the company’s stock worth $202,175,000 after acquiring an additional 75,352 shares during the last quarter. Pzena Investment Management LLC grew its holdings in shares of Concentrix by 32.3% during the fourth quarter. Pzena Investment Management LLC now owns 2,927,196 shares of the company’s stock worth $121,713,000 after purchasing an additional 714,604 shares in the last quarter. Dimensional Fund Advisors LP increased its position in shares of Concentrix by 28.4% in the fourth quarter. Dimensional Fund Advisors LP now owns 2,491,270 shares of the company’s stock worth $103,588,000 after purchasing an additional 551,778 shares during the last quarter. State Street Corp raised its stake in Concentrix by 8.7% in the second quarter. State Street Corp now owns 1,622,854 shares of the company’s stock valued at $85,776,000 after purchasing an additional 130,529 shares in the last quarter. Finally, 1832 Asset Management L.P. lifted its position in Concentrix by 3.1% during the second quarter. 1832 Asset Management L.P. now owns 1,544,997 shares of the company’s stock valued at $81,661,000 after purchasing an additional 46,856 shares during the last quarter. 90.34% of the stock is currently owned by hedge funds and other institutional investors.

Concentrix Company Profile

Concentrix Inc (NASDAQ: CNXC) is a global business services company specializing in customer engagement solutions and technology‐driven business process outsourcing. The firm’s offerings encompass customer care delivered across voice and digital channels, back‐office processing, analytics and consulting, and automated workflow management. By integrating proprietary platforms, strategic partnerships and advanced automation, Concentrix helps clients enhance customer experiences and streamline operations.

Its capabilities extend to digital marketing and technology implementation, leveraging artificial intelligence, machine learning and data analytics to optimize customer journeys.